Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients

Molecular Immunology
Frida C MohlinAnna M Blom

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a disease of complement dysregulation, characterized by hemolytic anemia, thrombocytopenia and acute renal failure. Mutations in complement inhibitors are major risk factors for development of aHUS. The three aHUS patients reported in this study had several previously identified alterations in complement inhibitors; e.g. risk haplotypes in CD46 and factor H but we also identified two novel heterozygous non-synonymous CD46 alterations (p.E142Q and p.G259V). Presence of G259V caused decreased expression of the recombinant mutant CD46 compared to wild type (WT). Western blot analysis showed that the majority of the expressed G259V protein was in the precursor form, suggesting that it is processed less efficiently than WT. Low CD46 expression on the surface of the patient's neutrophils confirmed the in vitro results. Further, G259V had a substantially impaired ability to act as a cofactor to factor I, in the degradation of both C3b and C4b. The E142Q mutant showed neither decreased expression nor impaired function. Two of the patients also had a heterozygous non-synonymous alteration in factor H (p.Q950H), reported previously in aHUS but not functionally tested. This variant showed moder...Continue Reading

References

Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·M ManchesterM B Oldstone
Apr 29, 1998·Kidney International·P WarwickerJ A Goodship
Oct 6, 1998·The Journal of Immunology : Official Journal of the American Association of Immunologists·M K LiszewskiJ P Atkinson
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Oct 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anna RichardsTimothy H J Goodship
Oct 30, 2003·Human Molecular Genetics·Jessica CaprioliUNKNOWN International Registry of Recurrent and Familial HUS/TTP
Jun 10, 2006·Journal of the American Society of Nephrology : JASN·Véronique Fremeaux-BacchiJohn P Atkinson
Dec 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Elena Goicoechea de JorgeSantiago Rodríguez de Córdoba
Apr 25, 2007·Nucleic Acids Research·Ian W DavisDavid C Richardson
Sep 18, 2008·Blood·Veronique Frémeaux-BacchiJohn P Atkinson
Apr 9, 2009·The Journal of Biological Chemistry·Markus J LehtinenT Sakari Jokiranta
Oct 23, 2009·The New England Journal of Medicine·Marina Noris, Giuseppe Remuzzi
May 3, 2011·Molecular Immunology·Sara C NilssonAnna M Blom
Mar 1, 2012·Journal of Thrombosis and Haemostasis : JTH·M RétiZ Prohászka
May 25, 2013·Biochemistry·Elisavet MakouPaul N Barlow
Jun 22, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Agnes SzilágyiZoltán Prohászka
Oct 29, 2013·Seminars in Nephrology·David KavanaghAnna Richards
Apr 15, 2014·Nucleic Acids Research·Elisa CiliaWim F Vranken

❮ Previous
Next ❯

Citations

Jun 10, 2015·Human Genomics·M Kathryn Liszewski, John P Atkinson
Jul 29, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joseph P GautCatherine E Cottrell
Jun 3, 2018·Journal of the American Society of Nephrology : JASN·Sjoerd A M E G TimmermansUNKNOWN Limburg Renal Registry
Jan 25, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Véronique Frémeaux-BacchiChantal Loirat
May 24, 2019·Frontiers in Immunology·Elisabetta ValotiMarina Noris
Nov 7, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kioa L WijnsmaJack F M Wetzels
Jul 10, 2020·Orphanet Journal of Rare Diseases·Lamisse Mansour-HendiliFrédéric Galactéros
Feb 12, 2017·Kidney International·Sjoerd A M E G TimmermansUNKNOWN Limburg Renal Registry
Jul 1, 2021·Blood·Hector Martín MerineroSantiago Rodríguez de Córdoba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.